Activated K-Ras, but Not H-Ras or N-Ras, Regulates Brain Neural Stem Cell Proliferation in a Raf/Rb-Dependent Manner

被引:21
|
作者
Bender, R. Hugh F. [1 ]
Haigis, Kevin M. [2 ]
Gutmann, David H. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Canc Res Inst, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
Neural stem cells; Ras proteins; Cell proliferation; Raf kinases; Retinoblastoma protein; CENTRAL-NERVOUS-SYSTEM; RB-RAF-1; INTERACTION; PROTEIN-KINASE; PLASMA-MEMBRANE; IN-VIVO; ASTROGLIAL DIFFERENTIATION; STIMULATES PROLIFERATION; PILOCYTIC ASTROCYTOMA; PROGENITOR CELLS; CEREBRAL-CORTEX;
D O I
10.1002/stem.1990
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Neural stem cells (NSCs) give rise to all the major cell types in the brain, including neurons, oligodendrocytes, and astrocytes. However, the intracellular signaling pathways that govern brain NSC proliferation and differentiation have been incompletely characterized to date. Since some neurodevelopmental brain disorders (Costello syndrome and Noonan syndrome) are caused by germline activating mutations in the RAS genes, Ras small GTPases are likely critical regulators of brain NSC function. In the mammalian brain, Ras exists as three distinct molecules (H-Ras, K-Ras, and N-Ras), each with different subcellular localizations, downstream signaling effectors, and biological effects. Leveraging a novel series of conditional-activated Ras molecule-expressing genetically engineered mouse strains, we demonstrate that activated K-Ras, but not H-Ras or N-Ras, expression increases brain NSC growth in a Raf-dependent, but Mek-independent, manner. Moreover, we show that activated K-Ras regulation of brain NSC proliferation requires Raf binding and suppression of retinoblastoma (Rb) function. Collectively, these observations establish tissue-specific differences in activated Ras molecule regulation of brain cell growth that operate through a noncanonical mechanism. Stem Cells2015;33:1998-2010
引用
收藏
页码:1998 / 2010
页数:13
相关论文
共 50 条
  • [1] N-RAS, H-RAS, AND K-RAS - A DIFFERENCE IN TRANSFORMING POTENTIAL
    MAHER, J
    BAKER, DA
    DIBB, NJ
    ROBERTS, IAG
    [J]. BLOOD, 1994, 84 (10) : A295 - A295
  • [2] EVIDENCE FOR CELL-SPECIFIC DIFFERENCES IN TRANSFORMATION BY N-RAS, H-RAS AND K-RAS
    MAHER, J
    BAKER, DA
    MANNING, M
    DIBB, NJ
    ROBERTS, IAG
    [J]. ONCOGENE, 1995, 11 (08) : 1639 - 1647
  • [3] H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers
    Przybojewska, B
    Jagiello, A
    Jalmuzna, P
    [J]. CANCER GENETICS AND CYTOGENETICS, 2000, 121 (01) : 73 - 77
  • [4] Mutation and expression analysis of K-Ras, H-Ras, N-Ras and B-Raf oncogenes in Wilms tumors
    Dalpa, Efterpi
    Gourvas, Victor
    Soulitzis, Nikolaos
    Spandidos, Demetrios A.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S93 - S93
  • [5] K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth
    Dalpa, Efterpi
    Gourvas, Victor
    Soulitzis, Nikolaos
    Spandidos, Demetrios A.
    [J]. MEDICAL ONCOLOGY, 2017, 34 (01)
  • [6] K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth
    Efterpi Dalpa
    Victor Gourvas
    Nikolaos Soulitzis
    Demetrios A. Spandidos
    [J]. Medical Oncology, 2017, 34
  • [7] ANALYSIS OF H-RAS, K-RAS AND N-RAS GENES FOR EXPRESSION, MUTATION AND AMPLIFICATION IN LARYNGEAL TUMORS
    KIARIS, H
    SPANDIDOS, DA
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 75 - 80
  • [8] Analysis of K-ras, N-ras, H-ras, and p53 in lung neuroendocrine neoplasms
    Couce, ME
    Bautista, D
    Costa, J
    Carter, D
    [J]. DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (02) : 71 - 79
  • [9] IMMUNOHISTOCHEMICAL DETECTION OF THE H-RAS, K-RAS, AND N-RAS ONCOGENES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    MCDONALD, JS
    JONES, H
    PAVELIC, ZP
    PAVELIC, LJ
    STAMBROOK, PJ
    GLUCKMAN, JL
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1994, 23 (08) : 342 - 346
  • [10] Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients
    Malgorzata Banys-Paluchowski
    Karin Milde-Langosch
    Tanja Fehm
    Isabell Witzel
    Leticia Oliveira-Ferrer
    Barbara Schmalfeldt
    Volkmar Müller
    [J]. Breast Cancer Research and Treatment, 2020, 179 : 403 - 414